BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20201079)

  • 1. Genetic deficiency of Syk protects mice from autoantibody-induced arthritis.
    Jakus Z; Simon E; Balázs B; Mócsai A
    Arthritis Rheum; 2010 Jul; 62(7):1899-910. PubMed ID: 20201079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lineage-Specific Analysis of Syk Function in Autoantibody-Induced Arthritis.
    Németh T; Futosi K; Szilveszter K; Vilinovszki O; Kiss-Pápai L; Mócsai A
    Front Immunol; 2018; 9():555. PubMed ID: 29616043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syk-dependent signaling pathways in neutrophils and macrophages are indispensable in the pathogenesis of anti-collagen antibody-induced arthritis.
    Ozaki N; Suzuki S; Ishida M; Harada Y; Tanaka K; Sato Y; Kono T; Kubo M; Kitamura D; Encinas J; Hara H; Yoshida H
    Int Immunol; 2012 Sep; 24(9):539-50. PubMed ID: 22914861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis.
    Jakus Z; Simon E; Frommhold D; Sperandio M; Mócsai A
    J Exp Med; 2009 Mar; 206(3):577-93. PubMed ID: 19273622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of Syk in neutrophils prevents immune complex arthritis.
    Elliott ER; Van Ziffle JA; Scapini P; Sullivan BM; Locksley RM; Lowell CA
    J Immunol; 2011 Oct; 187(8):4319-30. PubMed ID: 21918195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil functions and autoimmune arthritis in the absence of p190RhoGAP: generation and analysis of a novel null mutation in mice.
    Németh T; Futosi K; Hably C; Brouns MR; Jakob SM; Kovács M; Kertész Z; Walzog B; Settleman J; Mócsai A
    J Immunol; 2010 Sep; 185(5):3064-75. PubMed ID: 20675588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific inhibition of spleen tyrosine kinase suppresses leukocyte immune function and inflammation in animal models of rheumatoid arthritis.
    Coffey G; DeGuzman F; Inagaki M; Pak Y; Delaney SM; Ives D; Betz A; Jia ZJ; Pandey A; Baker D; Hollenbach SJ; Phillips DR; Sinha U
    J Pharmacol Exp Ther; 2012 Feb; 340(2):350-9. PubMed ID: 22040680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis.
    Jacobs JP; Pettit AR; Shinohara ML; Jansson M; Cantor H; Gravallese EM; Mathis D; Benoist C
    Arthritis Rheum; 2004 Aug; 50(8):2685-94. PubMed ID: 15334485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropeptide neuromedin U promotes autoantibody-mediated arthritis.
    Rao SM; Auger JL; Gaillard P; Weissleder R; Wada E; Torres R; Kojima M; Benoist C; Mathis D; Binstadt BA
    Arthritis Res Ther; 2012 Feb; 14(1):R29. PubMed ID: 22314006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model.
    Jacobs JP; Ortiz-Lopez A; Campbell JJ; Gerard CJ; Mathis D; Benoist C
    Arthritis Rheum; 2010 Jul; 62(7):1921-32. PubMed ID: 20506316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy.
    Liao C; Hsu J; Kim Y; Hu DQ; Xu D; Zhang J; Pashine A; Menke J; Whittard T; Romero N; Truitt T; Slade M; Lukacs C; Hermann J; Zhou M; Lucas M; Narula S; DeMartino J; Tan SL
    Arthritis Res Ther; 2013 Oct; 15(5):R146. PubMed ID: 24286216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective spleen tyrosine kinase inhibition delays autoimmune arthritis in mice.
    Zhang Z; Cao C; Sun S; Xu Q
    Mol Med Rep; 2015 Aug; 12(2):2902-6. PubMed ID: 25955571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a novel system for studying spleen tyrosine kinase function in macrophages and B cells.
    Miller AL; Zhang C; Shokat KM; Lowell CA
    J Immunol; 2009 Jan; 182(2):988-98. PubMed ID: 19124742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.
    Cook AD; De Nardo CM; Braine EL; Turner AL; Vlahos R; Way KJ; Beckman SK; Lenzo JC; Hamilton JA
    Arthritis Res Ther; 2010; 12(2):R37. PubMed ID: 20196869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spleen tyrosine kinase inhibition attenuates autoantibody production and reverses experimental autoimmune GN.
    McAdoo SP; Reynolds J; Bhangal G; Smith J; McDaid JP; Tanna A; Jackson WD; Masuda ES; Cook HT; Pusey CD; Tam FW
    J Am Soc Nephrol; 2014 Oct; 25(10):2291-302. PubMed ID: 24700868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host-derived CD4+ T cells attenuate stem cell-mediated transfer of autoimmune arthritis in lethally irradiated C57BL/6.g7 mice.
    Rajasekaran N; Wang N; Truong P; Rinderknecht C; Macaubas C; Beilhack GF; Shizuru JA; Mellins ED
    Arthritis Rheum; 2013 Mar; 65(3):681-92. PubMed ID: 23233229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transmission of antibody-induced arthritis is independent of complement component 4 (C4) and the complement receptors 1 and 2 (CD21/35).
    Solomon S; Kolb C; Mohanty S; Jeisy-Walder E; Preyer R; Schöllhorn V; Illges H
    Eur J Immunol; 2002 Mar; 32(3):644-51. PubMed ID: 11857338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD301b/MGL2
    Meier LA; Auger JL; Engelson BJ; Cowan HM; Breed ER; Gonzalez-Torres MI; Boyer JD; Verma M; Marath A; Binstadt BA
    Circulation; 2018 Jun; 137(23):2478-2493. PubMed ID: 29386201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new look at Syk in alpha beta and gamma delta T cell development using chimeric mice with a low competitive hematopoietic environment.
    Colucci F; Guy-Grand D; Wilson A; Turner M; Schweighoffer E; Tybulewicz VL; Di Santo JP
    J Immunol; 2000 May; 164(10):5140-5. PubMed ID: 10799872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CD34 leads to exacerbated autoimmune arthritis through increased vascular permeability.
    Blanchet MR; Gold M; Maltby S; Bennett J; Petri B; Kubes P; Lee DM; McNagny KM
    J Immunol; 2010 Feb; 184(3):1292-9. PubMed ID: 20038636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.